On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Apoptosis in C. elegans
- Two pathways of apoptosis in mammals
- Intrinsic apoptosis
- IAPs
- SMAC involvement in apoptosis
- Apoptosis pathways in mammals and Drozophila
- The essential N-terminal role of SMAC
- Illustration of SMAC
- Crystal structure of a variant of SMAC molecule
- XIAP-BIR3 binding amino acids
- Binding of SMAC to a conserved pocket on BIR
- Caspase-9 binds to IAPs
- Inhibition of caspase-9 by binding of XIAP
- A conserved active site conformation of caspases
- XIAP sequesters caspase-9 in a monomeric state
- CASP9 and SMAC bind to the same BIR domain
- IAPs inhibition of effector caspases
- Crystal structures of CASP7 and 3 bound to XIAP
- Structure of mature caspase-3 bound to BIR2
- Mechanism of inhibition by XIAP
- How can SMAC counter the inhibition?
- Activation of effector and initiator caspases
- A conserved active site conformation of caspases
- Caspase-7 zymogen conformation
- Active site conformation distortion in the zymogen
- Initiator caspases
- Intiator caspases activation by large complexed
- An assembly apoptosome model with Apaf-1
- Cryo-EM structure of Dark/Hac-1/Dapaf-1
- C. elegans genetically defined apoptosis pathway
- Biochemistry of the apoptotic pathway
- How does CED-9 negatively regulate CED-4?
- CED-4-CED-9 complex stoichiometry
- CED-4-CED-9 complex
- CED-4 binds to one ATP and one Mg ion
- How does CED-9 inhibit CED-4?
- Free CED-4 exhibits higher molecular weight
- Free CED-4 is a tetramer by EM
- Mutagenesis disruption of CED-4 oligomerization
- CED-4 tetramer only activates CED-3
- CED-9 blocks CED-4 from further dimerization
- EGL-1 release CED-4 from inhibitory complex
- Binding of CED-9 by EGL-1 C-terminus
- CED-9-EGL-1 exists as a single folding unit
- EGL-1 induces conformation changes in CED-9
- CED-4 and EGL-1 bind to different sites of CED-9
- EGL-1 displaces CED-9 from the complex
- EGL-1 binds to CED-9 with higher affinity
- Current model of the linear PCD pathway
- Apoptosis pathway diagram in three species
- Acknowledgments
Topics Covered
- Structural mechanism of IAP recognition by Smac/DIABLO
- Structural mechanism of caspase-9 inhibition by XIAP-BIR3
- Structural mechanism of effector caspase inhibition by XIAP
- Structural mechanism of initiator caspase activation
- Structural biology of the apoptosome
- Structural biology of the programmed cell death pathway in C. elegans
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Shi, Y. (2007, October 1). Mechanisms of apoptosis from structural biology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/BFPF5734.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Yigong Shi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.